Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis. (Q46002153)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis. |
scientific article |
Statements
1 reference
Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis. (English)
1 reference
S Rössner
1 reference
K Johansson
1 reference
K Neovius
1 reference
S M DeSantis
1 reference
M Neovius
1 reference
12 May 2009
1 reference
1 reference
10
1 reference
5
1 reference
564-575
1 reference
1 reference
Identifiers
1 reference
1 reference